Advertisement
Research Article Free access | 10.1172/JCI115983
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Jackson, S. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Kler, R. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Bartlett, K. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Briggs, H. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Bindoff, L. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Pourfarzam, M. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Gardner-Medwin, D. in: JCI | PubMed | Google Scholar
Division of Clinical Neuroscience, Medical School, University of Newcastle upon Tyne, United Kingdom.
Find articles by Turnbull, D. in: JCI | PubMed | Google Scholar
Published October 1, 1992 - More info
A young girl presented with recurrent episodes of muscle weakness culminating in a severe attack of generalized muscle weakness. In the muscle mitochondria from the patient there was an abnormal pattern of intermediates of beta-oxidation with an accumulation of 3-hydroxyacyl- and 2-enoyl-CoA and carnitine esters, and 3-oxoacylcarnitines. There was low activity of long-chain 3-hydroxyacyl-CoA dehydrogenase in mitochondria from all tissues. The activity of long-chain 2-enoyl-CoA hydratase was low in muscle mitochondria and 3-oxoacyl-CoA thiolase activity measured with 3-oxohexadecanoyl-CoA as substrate was low in fibroblast, muscle, and cardiac mitochondria but only partial deficiency was present when the activity was measured with 3-oxooctanoyl-CoA. The activity of the long-chain 3-hydroxyacyl-CoA dehydrogenase and long-chain 3-oxoacyl-CoA thiolase in fibroblasts from the patient's parents was intermediate between those of controls and the patient. The patient has a combined defect of the long-chain 3-hydroxyacyl-CoA dehydrogenase, long-chain 3-oxoacyl-CoA thiolase, and long-chain 2-enoyl-CoA hydratase which appears to be inherited in an autosomal recessive manner. This suggests there is a multifunctional enzyme catalyzing these activities in human mitochondria and that this enzyme is deficient in our patient.